Keynote Presentation: Demystifying Cannabis: A Need for Universal Product Taxonomy for Informed Choices with Live Q&A

The cannabis plant is rich in active compounds, including the well-known phytocannabinoids Delta-9 (Δ-9) THC and CBD, which are synthesized by all cannabis plants as acids (Δ-9 THCA and CBDA). While THCA and CBDA are the most dominant cannabinoids, cannabis also generates a variety of minor phytocannabinoids throughout its growth cycle. Beyond these plant-synthesized molecules, our bodies produce endocannabinoids that, along with phytocannabinoids, interact with cannabinoid and other receptors in our bodies and brains, resulting in diverse therapeutic effects. However, the current cannabinoid market resembles a wild west of unvalidated claims and unnecessary synthetic hemp derivatives, creating risks and confusion for both consumers and regulators. This situation underscores the urgent need for a universal cannabis product taxonomy—a standardized and transparent system that categorizes products based on their true active ingredients, rather than relying on outdated labels, strain names, or indica versus sativa designations. Implementing such a system is crucial for ensuring consumer safety and supporting informed decision-making.

Learning Objectives: 

1. Describe the key active compounds in cannabis, including major and minor phytocannabinoids, and their interactions with the endocannabinoid system.

2. Analyze the challenges posed by the lack of standardized cannabis product labeling and the risks associated with unvalidated claims and synthetic derivatives.

3. Propose a framework for a universal cannabis product taxonomy to improve consumer safety and informed decision-making.